BRN 2.38% 20.5¢ brainchip holdings ltd

Hi , there have been ocasi okns were the status are not updated....

  1. 432 Posts.
    lightbulb Created with Sketch. 476
    Hi , there have been ocasi okns were the status are not updated. Mesoblast has conducted ards trial and last i checked few weeks back its status wasnt changed.

    But since you raised the point it made we curious why the status isn't updated if my above reason is not the case.

    i dug in to all the fda requests submitted by nanose and i found a trial where the end date is April 2021 which is what we have been told would be a month of announcement.


    Hide glossary

    Glossary

    Study record managers: refer to the Data Element Definitions if submitting registration or results information.
    Search for terms
    x

    Accepts healthy volunteers

    Active comparator arm

    Adverse event

    Age or age group

    All-cause mortality

    Allocation

    Arm

    Arm type

    Baseline characteristics

    Canceled submission

    Certain agreements

    Certification

    Certification/extension first posted

    Certification/extension first submitted

    Certification/extension first submitted that met QC criteria

    City and distance

    Clinical study

    Clinical trial

    ClinicalTrials.gov identifier (NCT number)

    Collaborator

    Condition/disease

    Contact

    Country

    Cross-over assignment

    Data Monitoring Committee (DMC)

    Early Phase 1 (formerly listed as Phase 0)

    Eligibility criteria

    Enrollment

    Exclusion criteria

    Expanded access

    Expanded access status

    Expanded access type

    Experimental arm

    Extension request

    Factorial assignment

    FDAAA 801 Violations

    First posted

    First submitted

    First submitted that met QC criteria

    Food and Drug Administration Amendments Act of 2007, Section 801 (FDAAA 801)

    Funder type

    Gender-based eligibility

    Group/cohort

    Human subjects protection review board

    Inclusion criteria

    Informed consent

    Informed consent form (ICF)

    Intervention model

    Intervention/treatment

    Interventional study (clinical trial)

    Investigator

    Last update posted

    Last update submitted

    Last update submitted that met QC criteria

    Last verified

    Listed location countries

    Location terms

    Masking

    NCT number

    No intervention arm

    Observational study

    Observational study model

    Other adverse event

    Other study IDs

    Other terms

    Outcome measure

    Parallel assignment

    Participant flow

    Patient registry

    Phase

    Phase 1

    Phase 2

    Phase 3

    Phase 4

    Phase Not Applicable

    Placebo

    Placebo comparator arm

    Primary completion date

    Primary outcome measure

    Primary purpose

    Principal investigator (PI)

    Protocol

    Quality control (QC) review

    Randomized allocation

    Recruitment status

    Registration

    Removed location countries

    Reporting group

    Responsible party

    Results database

    Results delayed

    Results first posted

    Results first submitted

    Results first submitted that met QC criteria

    Results returned after quality control review

    Results submitted to ClinicalTrials.gov

    Secondary outcome measure

    Serious adverse event

    Sex

    Sham comparator arm

    Single group assignment

    Sort studies by

    Sponsor

    State

    Statistical analysis plan (SAP)

    Status

    Study completion date

    Study design

    Study documents

    Study IDs

    Study record

    Study registry

    Study results

    Study start date

    Study type

    Submitted date

    Title

    Title acronym

    U.S. Agency for Healthcare Research and Quality (AHRQ)

    U.S. Food and Drug Administration (FDA)

    Unknown

    Skip to Main Content





    Home

    Search Results

    Study Record Detail

     Save this study

    Trial record 7 of 15 for:    Na-nose

    Previous Study | Return to List | Next Study

    Detection of Placenta Accreta Via Exhaled Women Breath

    The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

     

    ClinicalTrials.gov Identifier: NCT03947047

    Recruitment Status  : Recruiting

    First Posted  : May 13, 2019

    Last Update Posted  : August 13, 2019

    See Contacts and Locations

    Sponsor:

    HaEmek Medical Center, Israel

    Collaborator:

    Technion, Israel Institute of Technology

    Information provided by (Responsible Party):

    Sivan Easton, HaEmek Medical Center, Israel


    Study Details

    Tabular View

    No Results Posted

    Disclaimer

    How to Read a Study Record




    all trials details

    https://clinicaltrials.gov/ct2/show/NCT03947047?term=Na-nose&draw=2&rank=7
    https://hotcopper.com.au/data/attachments/2954/2954249-1355f25e5b0381584861c498047528bb.jpg
    https://hotcopper.com.au/data/attachments/2954/2954252-7d3a49961c593a58013f87f475e24bd2.jpg
    https://hotcopper.com.au/data/attachments/2954/2954255-aa2eb035ff49a6925bc4ced2a7c32238.jpg
    Last edited by Drifter16: 27/02/21
 
watchlist Created with Sketch. Add BRN (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
-0.005(2.38%)
Mkt cap ! $380.4M
Open High Low Value Volume
21.0¢ 22.0¢ 20.3¢ $1.148M 5.421M

Buyers (Bids)

No. Vol. Price($)
8 165683 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 10000 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
BRN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.